Guangxun Gao

机构：Xijing Hospital, Air Force Medical University · ORCID：0000-0002-9859-4198

发表论文 155 篇 · 总被引 1493 次 · h-index 22

代表论文

• Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial (2025 · The Lancet · 被引 20)
• Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCD (2024 · Blood Advances · 被引 6)
• Recommendations for the timing, dosage, and usage of corticosteroids during cytokine release syndrome (CRS) caused by chimeric antigen receptor (CAR)-T cell therapy for hematologic malignancies (2024 · Chinese Medical Journal · 被引 5)
• Dose-optimised recombinant human thrombopoietin versus eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study) (2025 · EClinicalMedicine · 被引 4)
• Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease (2024 · Cancer Pathogenesis and Therapy · 被引 4)
• Development and validation of a prognostic staging system for primary plasma cell leukemia (2025 · Journal of Hematology & Oncology · 被引 3)